Wat is de prijs voor Eastgate Biotech Corp. (ETBI)

Het prijs van Eastgate Biotech Corp. (ETBI) is $0.003

Wat is de marktkapitalisatie voor Eastgate Biotech Corp. (ETBI)

Marktkapitalisatie voorEastgate Biotech Corp. (ETBI) is $6.17M

Eastgate Biotech Corp. (ETBI) Dividendrendement

EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.

Jaar	Dividendrendement	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Dividendrendement

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Dividendrendement	Land
Royalty Pharma plc RPRX.US	1.58%	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	SE
Ipsen S.A. IPN.PA	0.00%	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	IT
Corcept Therapeutics Incorporated CORT.US	0.00%	US

Bedrijf

Dividendrendement

Land